Domov › Rakovina pečene (hepatocelulárny karcinóm) › Pennsylvania
Klinické štúdie Rakovina pečene (hepatocelulárny karcinóm) v štáte Pennsylvania
27 štúdií pre Rakovina pečene (hepatocelulárny karcinóm) hľadá účastníkov v zariadeniach v štáte Pennsylvania.
Mestá v štáte Pennsylvania
Oficiálny text štúdie (anglicky)
A Phase 1 Study of the Safety and Tolerability of CTX-10726
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07419841Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #104, Hershey
- Exelixis Clinical Site #98, Philadelphia
- Exelixis Clinical Site #32, Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05176483National Liver Cancer Screening Trial
- University of Pennsylvania, Philadelphia
Prebieha náborFáza 4
Vek 18 až 85 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06084234A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT06427941Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- Lehigh Valley Hospital, Allentown
Prebieha náborObservačná štúdia
Vek 22 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT06486454Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06811116Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Philadelphia
- Research Site, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06921785Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Prebieha náborFáza 1/2
12 Months – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04851119FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- a 2 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT07166406Molecular Basis of Pediatric Liver Cancer
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Prebieha náborObservačná štúdia
Vek 0 až 99 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT03959800Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Allegheny General Hospital, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT05168163A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Thomas Jefferson University, Philadelphia
Prebieha náborFáza 2
Vek 8 a viac · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT05503797Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT04114136A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Pittsburgh
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT06600321Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Prebieha nábor
Vek 18 až 75 · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT05486572Y-90 Treatment Response Using Transarterial Radioembolization
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT07145801Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- University of Pennsylvania, Philadelphia
Prebieha náborFáza 1/2
Vek 20 až 99 · Všetky pohlavia · Aktualizované 20. 4. 2026 · NCT02174549Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 4. 2026 · NCT07223424Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 4. 2026 · NCT05842174Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 4. 2026 · NCT05733598SBRT With Atezo/Bev for HCC
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Prebieha náborFáza 1
Vek 18 až 99 · Všetky pohlavia · Aktualizované 20. 2. 2026 · NCT05488522Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
- Thomas Jefferson Hospital, Philadelphia
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 1. 2026 · NCT05705219Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Penn State Hershey Medical Center, Hershey
- Albert Einstein Healthcare Network, Philadelphia
Prebieha náborFáza 4
Vek 18 až 64 · Všetky pohlavia · Aktualizované 22. 1. 2026 · NCT04373564Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 1. 2026 · NCT03539822Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
- UPMC Hillman Cancer Center, Pittsburgh
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 11. 2025 · NCT06698250SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.